The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Recommendation of “Hold” from Brokerages

The Beauty Health Company (NASDAQ:SKIN) has been assigned an average rating of “Hold” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $2.02.

SKIN has been the subject of several recent analyst reports. Canaccord Genuity Group decreased their price objective on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Friday, May 1st. Benchmark reissued a “hold” rating on shares of Beauty Health in a research note on Friday, March 13th. Zacks Research raised shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. TD Cowen lowered their target price on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research note on Monday, March 16th. Finally, Roth Mkm reissued a “buy” rating and set a $2.00 target price (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th.

Beauty Health Price Performance

SKIN stock opened at $0.65 on Thursday. The company has a fifty day moving average price of $0.74 and a 200-day moving average price of $1.07. The company has a market capitalization of $84.76 million, a P/E ratio of -3.85 and a beta of 1.09. Beauty Health has a 52-week low of $0.55 and a 52-week high of $2.69. The company has a debt-to-equity ratio of 4.37, a quick ratio of 1.48 and a current ratio of 1.79.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.04. The firm had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. As a group, equities analysts expect that Beauty Health will post -0.14 EPS for the current year.

Hedge Funds Weigh In On Beauty Health

Hedge funds have recently bought and sold shares of the company. Mirabella Financial Services LLP raised its stake in Beauty Health by 21.3% during the third quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after buying an additional 2,734,728 shares during the last quarter. Hillsdale Investment Management Inc. acquired a new stake in Beauty Health in the third quarter worth $293,000. Renaissance Technologies LLC grew its holdings in Beauty Health by 29.6% in the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock worth $253,000 after purchasing an additional 64,900 shares during the period. Capricorn Fund Managers Ltd acquired a new stake in Beauty Health in the first quarter worth $17,270,000. Finally, Diversified Trust Co acquired a new stake in Beauty Health in the first quarter worth $25,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.